Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients (Q38989354)

8 September 2017

Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients (English)

1 reference

hypertrophic cardiomyopathy

8 September 2017

1 reference

Sonia A El-Saiedi

1

1 reference

8 September 2017

Zeinab S Seliem

series ordinal

2

1 reference

8 September 2017

Reem I Esmail

series ordinal

3

1 reference

8 September 2017

language of work or name

1 reference

29 July 2013

1 reference

8 September 2017

Cardiology in the Young

1 reference

8 September 2017

24

1 reference

8 September 2017

4

1 reference

8 September 2017

702-708

1 reference

Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.

8 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Hypertrophic cardiomyopathy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Hypertrophic cardiomyopathy in infants: clinical features and natural history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Theoretical and empirical derivation of cardiovascular allometric relationships in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Design and implementation of the North American Pediatric Cardiomyopathy Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Clinical practice. Hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

Hypertrophic cardiomyopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Verapamil therapy in infants with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Tetralogy of Fallot and hypertrophic cardiomyopathy: a rare association

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

An unusual case of cyanotic heart disease in a patient with patent foramen ovale and right ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Europ

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1047951113001030

7 January 2021

10.1017/S1047951113001030

Identifiers

DOI

1 reference

8 September 2017

1 reference